CN1486693A - 一种奥拉西坦冻干粉针剂的制备方法及制品 - Google Patents
一种奥拉西坦冻干粉针剂的制备方法及制品 Download PDFInfo
- Publication number
- CN1486693A CN1486693A CNA031389988A CN03138998A CN1486693A CN 1486693 A CN1486693 A CN 1486693A CN A031389988 A CNA031389988 A CN A031389988A CN 03138998 A CN03138998 A CN 03138998A CN 1486693 A CN1486693 A CN 1486693A
- Authority
- CN
- China
- Prior art keywords
- oxiracetam
- injection
- preparation
- water
- sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- IHLAQQPQKRMGSS-UHFFFAOYSA-N oxiracetam Chemical compound NC(=O)CN1CC(O)CC1=O IHLAQQPQKRMGSS-UHFFFAOYSA-N 0.000 title claims abstract description 46
- 229960001227 oxiracetam Drugs 0.000 title claims abstract description 45
- 239000000843 powder Substances 0.000 title claims abstract description 17
- 238000002347 injection Methods 0.000 title abstract description 15
- 239000007924 injection Substances 0.000 title abstract description 15
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- 238000002360 preparation method Methods 0.000 claims abstract description 23
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 18
- UOQHWNPVNXSDDO-UHFFFAOYSA-N 3-bromoimidazo[1,2-a]pyridine-6-carbonitrile Chemical compound C1=CC(C#N)=CN2C(Br)=CN=C21 UOQHWNPVNXSDDO-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229940099563 lactobionic acid Drugs 0.000 claims abstract description 11
- 238000001914 filtration Methods 0.000 claims abstract description 9
- 238000005303 weighing Methods 0.000 claims abstract description 9
- 238000010438 heat treatment Methods 0.000 claims abstract description 3
- 239000000706 filtrate Substances 0.000 claims description 22
- 238000001035 drying Methods 0.000 claims description 17
- 239000008215 water for injection Substances 0.000 claims description 16
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 9
- 229910052708 sodium Inorganic materials 0.000 claims description 9
- 239000011734 sodium Substances 0.000 claims description 9
- 239000001509 sodium citrate Substances 0.000 claims description 9
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 9
- 239000000600 sorbitol Substances 0.000 claims description 9
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 8
- 238000005262 decarbonization Methods 0.000 claims description 7
- 239000012528 membrane Substances 0.000 claims description 7
- 210000004907 gland Anatomy 0.000 claims description 2
- 239000000243 solution Substances 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 2
- 238000004108 freeze drying Methods 0.000 abstract description 21
- 239000011521 glass Substances 0.000 abstract description 6
- MEIRRNXMZYDVDW-MQQKCMAXSA-N (2E,4E)-2,4-hexadien-1-ol Chemical compound C\C=C\C=C\CO MEIRRNXMZYDVDW-MQQKCMAXSA-N 0.000 abstract 2
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- AQKFVNLHZYOMKQ-WWNCWODVSA-M sodium;(2r,3r,4r,5r)-2,3,5,6-tetrahydroxy-4-[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexanoate Chemical compound [Na+].[O-]C(=O)[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O AQKFVNLHZYOMKQ-WWNCWODVSA-M 0.000 abstract 2
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 238000007789 sealing Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 description 10
- 238000000859 sublimation Methods 0.000 description 10
- 230000008022 sublimation Effects 0.000 description 10
- 238000000034 method Methods 0.000 description 7
- 229910052782 aluminium Inorganic materials 0.000 description 5
- 230000003115 biocidal effect Effects 0.000 description 5
- 229920005549 butyl rubber Polymers 0.000 description 5
- 230000005496 eutectics Effects 0.000 description 5
- 239000006166 lysate Substances 0.000 description 5
- 238000012423 maintenance Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229960002298 aminohydroxybutyric acid Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 231100000025 genetic toxicology Toxicity 0.000 description 1
- 230000001738 genotoxic effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 239000002664 nootropic agent Substances 0.000 description 1
- 230000001777 nootropic effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- YHHSONZFOIEMCP-UHFFFAOYSA-O phosphocholine Chemical compound C[N+](C)(C)CCOP(O)(O)=O YHHSONZFOIEMCP-UHFFFAOYSA-O 0.000 description 1
- 229950004354 phosphorylcholine Drugs 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03138998 CN1287788C (zh) | 2003-08-08 | 2003-08-08 | 一种奥拉西坦冻干粉针剂的制备方法及制品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03138998 CN1287788C (zh) | 2003-08-08 | 2003-08-08 | 一种奥拉西坦冻干粉针剂的制备方法及制品 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1486693A true CN1486693A (zh) | 2004-04-07 |
CN1287788C CN1287788C (zh) | 2006-12-06 |
Family
ID=34155005
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 03138998 Expired - Lifetime CN1287788C (zh) | 2003-08-08 | 2003-08-08 | 一种奥拉西坦冻干粉针剂的制备方法及制品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1287788C (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101396358B (zh) * | 2007-09-25 | 2011-10-12 | 广东世信药业有限公司 | 奥拉西坦注射液 |
CN102274195A (zh) * | 2011-07-18 | 2011-12-14 | 石药集团欧意药业有限公司 | 一种奥拉西坦冻干粉针制剂及其制备方法 |
CN102512378A (zh) * | 2011-12-09 | 2012-06-27 | 天津市汉康医药生物技术有限公司 | 稳定安全的供注射用奥拉西坦药物组合物 |
CN102670527A (zh) * | 2012-05-28 | 2012-09-19 | 南京优科生物医药研究有限公司 | 左旋奥拉西坦的冻干粉针剂及其制备工艺 |
CN103446067A (zh) * | 2013-09-16 | 2013-12-18 | 石药集团欧意药业有限公司 | 注射用奥拉西坦冻干制剂及其制备方法 |
CN104069074A (zh) * | 2013-03-29 | 2014-10-01 | 重庆药友制药有限责任公司 | 一种注射用奥拉西坦及其制备方法 |
-
2003
- 2003-08-08 CN CN 03138998 patent/CN1287788C/zh not_active Expired - Lifetime
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101396358B (zh) * | 2007-09-25 | 2011-10-12 | 广东世信药业有限公司 | 奥拉西坦注射液 |
CN102274195A (zh) * | 2011-07-18 | 2011-12-14 | 石药集团欧意药业有限公司 | 一种奥拉西坦冻干粉针制剂及其制备方法 |
CN102512378A (zh) * | 2011-12-09 | 2012-06-27 | 天津市汉康医药生物技术有限公司 | 稳定安全的供注射用奥拉西坦药物组合物 |
CN102670527A (zh) * | 2012-05-28 | 2012-09-19 | 南京优科生物医药研究有限公司 | 左旋奥拉西坦的冻干粉针剂及其制备工艺 |
CN104069074A (zh) * | 2013-03-29 | 2014-10-01 | 重庆药友制药有限责任公司 | 一种注射用奥拉西坦及其制备方法 |
CN104069074B (zh) * | 2013-03-29 | 2018-04-17 | 重庆药友制药有限责任公司 | 一种注射用奥拉西坦及其制备方法 |
CN103446067A (zh) * | 2013-09-16 | 2013-12-18 | 石药集团欧意药业有限公司 | 注射用奥拉西坦冻干制剂及其制备方法 |
CN103446067B (zh) * | 2013-09-16 | 2015-06-17 | 石药集团欧意药业有限公司 | 注射用奥拉西坦冻干制剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1287788C (zh) | 2006-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103446067B (zh) | 注射用奥拉西坦冻干制剂及其制备方法 | |
CN104042572B (zh) | 一种含福沙匹坦二甲葡胺的注射用组合物及其制备方法 | |
CN102512378B (zh) | 稳定安全的供注射用奥拉西坦药物组合物 | |
CN1287788C (zh) | 一种奥拉西坦冻干粉针剂的制备方法及制品 | |
CN101224196A (zh) | 一种盐酸氨溴索冻干粉针及其制备方法 | |
CN100496463C (zh) | 一种奥美拉唑钠冻干粉针剂及其制备方法 | |
CN102258488B (zh) | 一种注射用克林霉素磷酸酯组合物及其制备方法 | |
CN105078906A (zh) | 一种含尿激酶的药物冻干制剂及其制备方法 | |
CN100506215C (zh) | 一种头孢硫脒冻干粉针的制备方法 | |
CN102552175B (zh) | 一种注射用磷酸氟达拉滨冻干制剂及其制备方法 | |
CN102276533B (zh) | 一种新的奥扎格雷钠化合物及其药物组合物 | |
CN101972248B (zh) | 一种供注射用的法莫替丁组合物及其制备方法 | |
CN105640899A (zh) | 供注射用泰地唑胺药物组合物 | |
CN103585018A (zh) | 一种注射用还原型谷胱甘肽的新冻干方法 | |
CN103494779B (zh) | 一种注射用炎琥宁粉针制剂及其制备方法 | |
CN102579370A (zh) | 含左卡尼汀衍生物的药物组合物及其制备方法 | |
CN101138553A (zh) | 注射用山莨菪碱冻干制剂及制备方法 | |
CN112076162A (zh) | 一种注射用哌拉西林钠他唑巴坦钠丙磺舒钠三方冻干制剂 | |
CN103494778B (zh) | 一种埃索美拉唑钠冻干制剂及其制备方法 | |
CN1562000A (zh) | 4-羟基-2-氧代-1-吡咯烷乙酰胺冻干制剂及其制备方法 | |
CN104958255B (zh) | 一种氟马西尼注射液及其制备方法 | |
CN105434368A (zh) | 一种注射用还原型谷胱甘肽及其预冻方法 | |
CN108815124A (zh) | 一种注射用盐酸多西环素冻干粉针剂及其制备方法 | |
CN1456162A (zh) | 左亚叶酸钙的注射药剂及制备方法 | |
CN108542855A (zh) | 一种含有蝇蛆虫体生物活性组分的美白护肤品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Medisan Pharmaceutical Co.,Ltd. Harbin Assignor: ZhuGe Guomin|ZhuGe Huaming Contract record no.: 2011110000199 Denomination of invention: Prepn and product of oxiracetam powder for injection Granted publication date: 20061206 License type: Exclusive License Open date: 20040407 Record date: 20111226 |
|
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: ZHUGE GUOMIN Effective date: 20130917 Owner name: JINAN DUNDAO TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: ZHUGE HUAMING Effective date: 20130917 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 250000 JINAN, SHANDONG PROVINCE TO: 250001 JINAN, SHANDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130917 Address after: 250001 Shandong Province, Ji'nan City District People's livelihood Street No. 22 Sanfrecce Silver Court Room B901 Patentee after: Jinan Road-following Technology Co.,Ltd. Address before: The people's livelihood Street in Ji'nan city of Shandong province in 250000 No. 22 Sanfrecce Silver Court B 22 storey building room B, Ji'nan Methodist Technology Co. Ltd. Patentee before: Zhuge Huaming Patentee before: Zhuge Guomin |
|
DD01 | Delivery of document by public notice |
Addressee: Zhuge Huaming Document name: Notification of Passing Examination on Formalities |
|
EM01 | Change of recordation of patent licensing contract |
Change date: 20140711 Contract record no.: 2011110000199 The licensee after: HARBIN MEDISAN PHARMACEUTICAL Co.,Ltd. The licensee before: Medisan Pharmaceutical Co.,Ltd. Harbin Change date: 20140711 Contract record no.: 2011110000199 Licensor after: Jinan Road-following Technology Co.,Ltd. Licensor before: Zhuge Huaming Licensor before: Zhuge Guomin |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
EC01 | Cancellation of recordation of patent licensing contract | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: HARBIN MEDISAN PHARMACEUTICAL Co.,Ltd. Assignor: Jinan Road-following Technology Co.,Ltd. Contract record no.: 2011110000199 Date of cancellation: 20170122 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20040407 Assignee: HARBIN MEDISAN PHARMACEUTICAL Co.,Ltd. Assignor: Jinan Road-following Technology Co.,Ltd. Contract record no.: 2017990000039 Denomination of invention: Prepn and product of oxiracetam powder for injection Granted publication date: 20061206 License type: Exclusive License Record date: 20170125 |
|
EC01 | Cancellation of recordation of patent licensing contract | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: HARBIN MEDISAN PHARMACEUTICAL Co.,Ltd. Assignor: Jinan Road-following Technology Co.,Ltd. Contract record no.: 2017990000039 Date of cancellation: 20180321 |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180416 Address after: 150025 Beijing Road, Limin Development Zone, Harbin, Heilongjiang Patentee after: HARBIN MEDISAN PHARMACEUTICAL Co.,Ltd. Address before: 250001 Shandong Province, Ji'nan City District People's livelihood Street No. 22 Sanfrecce Silver Court Room B901 Patentee before: Jinan Road-following Technology Co.,Ltd. |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20061206 |